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Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are now established features
of the atherosclerotic plaque. In this issue, Thorp et al. (2009) provide initial insights into the causative relation-
ship between UPR and the atherosclerotic disease process, specifically linking the proapoptotic mediator
CHOP to plaque growth and necrosis.Atherosclerosis is a progressive disease
characterized by development of lipid-
rich lesions in the subendothelial space of
large arteries and the primary cause of
heart disease and stroke. While the initial
stages are relatively benign, increases in
plaque size and complexity significantly
elevate the risk of acute clinical events.
The cellular and anatomical features of
advanced human plaques that are
unstable or so-called ‘‘vulnerable’’ to
rupture include a large acellular necrotic
core enriched in lipids and cell debris,
a reduced smooth muscle cell-containing
‘‘fibrous cap,’’ and an increased rate of
inflammation and cell death (Virmani
et al., 2006). The molecular mechanisms
underlying these changes are of critical
importance for clinical disease manage-
ment. Whereas the actual causes under-
lying the cellular demise in lesions are not
entirely understood, several cytotoxic
molecules are known to be enriched in
advanced atheromas (e.g., oxidized lipids,
excessive amounts of free cholesterol,
reactive oxygen radicals), and these can
induce apoptotic cell death in macro-
phages, endothelial cells, and vascular
smooth muscle cells (VSMC). A recent
series of papers have demonstrated that
ER stress and the UPR pathway is acti-
vated in human andmouse atherosclerotic
lesions, implicating this pathway as a
potential mechanism contributing to
lesional cell death, inflammation, and
disease progression (see Thorp et al.,
2009). The in vivo experimental evidence
for a role of UPR in plaque development,
however, has been lacking. Thorp et al.
now address this issue by specifically
examining the deficiency of the proapop-
totic UPRmediator CHOP in two common
murine models of atherosclerosis (Thorp
et al., 2009).The UPR pathway activates cellular
repair mechanisms, which are central to
the ability of cell to copewith insults nega-
tively affecting ER function. Under condi-
tions of severe and irreversible damage,
activation of the UPR can also lead to
apoptosis, which is mediated by induction
of transcription factor CHOP. While the
mechanisms by which CHOP activates
the apoptotic cell death are still being
defined, its critical role in mediating the
ERstress-inducedapoptosis iswell estab-
lished (Mungrue et al., 2009; Oyadomari
and Mori, 2004). Of particular significance
to its proposed role in atherogenesis,
CHOP expression is elevated in human
atherosclerotic lesions, particularly in
advanced plaques prone to rupture (My-
oishi et al., 2007). In addition, in vitro
studies in macrophages and vascular
smooth muscle cells have shown that
CHOP deficiency or siRNA-mediated
knockdown of CHOP protects cells from
apoptosis induced by molecules enriched
in atheromas, such as free cholesterol
loading or treatment with 7-ketocholes-
terol (Feng et al., 2003; Myoishi et al.,
2007).
To interrogate the impact of CHOP defi-
ciency on atherosclerotic plaque forma-
tion, Thorp et al. placed Chop/ mice
onto Apoe/ and Ldlr/ background,
twocommonmurinemodelsof atherogen-
esis. They show that Chop//Apoe/
double-knockout mice develop signifi-
cantly less lesions in aortic root (35%)
than their wild-type CHOP counterparts
when fed a high-fat and high-cholesterol
diet for 10 weeks. To confirm these find-
ings, the authors also carried out a sec-
ond study, this time utilizing the Chop//
Ldlr/ model and obtained essentially
the same results. Interestingly, no differ-
ences could be observed at early stagesCell Metaboof lesion development (4 weeks on diet).
Even though only relatively small number
of animals were utilized (n = 6 per group),
these data suggest that CHOP affects
lesion formation primarily in the more
advanced stages. As CHOP deficiency is
predicted to reduce apoptosis in the
context of ER stress, Thorp et al. (2009)
went on to characterize the lesions for
featuresof apoptoticcell death andplaque
necrosis. In both animal models, necrotic
areas present in atheromas of Chop/
mice were substantially reduced. Impor-
tantly, this decrease was more robust
(40%–50%) than one would expect to
occur solely based on a decrease in total
plaque area (35%). They postulate that
macrophageapoptosis representsamajor
contributing factor to necrotic core
enlargement. To support these claims
they analyzed a subgroup of mice from
Apoe/ cohort with identical mean lesion
size and demonstrate reduced necrosis
in this Chop//Apoe/ subgroup.
Although similar analysis was not carried
out in Ldlr/, these data do support
a role of CHOP as a contributing factor in
intimal apoptotic cell death and necrotic
core formation. Indeed, lesions from
Chop/ mice in both models contained
a lower number of cells exhibiting signs
of apoptosis. Given that macrophages
represent the major cell type occupying
the intima and surround the necrotic
core, the authors suggest that macro-
phage apoptosis is an important contrib-
utor to observed changes in plaque
necrosis. They support this hypothesis by
in situ immunohistochemistry analyses of
apoptotic cell distributions. Thorp et al.
also demonstrate that Chop/ peritoneal
macrophages are resistant to apoptosis
induced by several relevant ER stressors
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PreviewsFigure 1. Schematic Diagram Illustrating Potential Roles of ER Stress and CHOP in the Atherosclerotic Lesion Development
Early lesions are exemplified by so called ‘‘fatty streaks’’ containing cholesterol-enriched ‘‘foamy’’ macrophages (shown in blue, with yellow lipid droplets) in the
subendothelial space of lesion intima. During these early stages of the lesion development, the level of cytotoxic substances (e.g., oxysterols) is insufficient to
overwhelm themetabolic capacity of macrophages, and the CHOP branch of the UPR is not activated. Under these conditions, the UPR activation leads primarily
to cell repair, very low occurrence of apoptosis (shown in black), and minimal or absent necrotic core (shown in gray with red cholesterol crystals and black cell
debris). As the lesion progresses to its advanced stages, the level of ER stress in macrophages becomes too severe (indicated as orange-coloredmacrophages),
leading to CHOP induction and apoptosis. The apoptotic cells, if not cleared via phagocytosis, can undergo secondary necrosis and amplification of the necrotic
core size. It is plausible that similar processes are also taking place in other cell types, such as smooth muscle cells (shown in green), resulting in thinning of the
fibrous cap layer and further destabilization of the atherosclerotic plaque.effect on the ability of macrophages
to phagocytose apoptotic cells in vitro.
On the contrary, the ability of macro-
phages to clear apoptotic cells can be
compromised in atherosclerotic plaques
(Schrijvers et al., 2005). The actual impact
of CHOP deficiency on phagocytic func-
tion of macrophages has not been evalu-
ated in vivo, and therefore it cannot be
completely excluded.
The current study by Thorp et al. adds
important relevance to previous observa-
tions illustrating activation of UPR
pathway in atherosclerotic lesions. As
UPR induction can lead to either cell repair
or apoptosis, it was not clear to which
extent this pathway truly contributes to
lesional cell death and atherogenesis
in vivo. This study provides the first direct
causal link between UPR and atheroscle-
rotic disease and strongly supports the
hypothesis that ER stress, via CHOP-400 Cell Metabolism 9, May 6, 2009 ª2009mediated apoptosis, enhances advanced
lesion development and the occurrence of
plaque necrosis (see Figure 1). The net
contribution of macrophages to these
findings is strongly implied, but as authors
point out, further studies are needed to
address this issue. As a case in point,
apoptosis of VSMCs can also enhance
atherosclerosis, increase the size of the
necrotic core, and lead to thinning of the
fibrous cap (Clarke et al., 2008). CHOP
is known to be ubiquitously expressed,
and the siRNA-mediated knockdown of
CHOP in human VSMCs reduces the
apoptotic cell death in response to 7-keto-
cholesterol (Myoishi et al., 2007). Further-
more, the UPR molecules in endothelial
cells were also shown to be elevated in
human atherosclerosis (Gargalovic et al.,
2006). Therefore, it remains to be resolved
whether CHOP deficiency also affects
apoptosis of smooth muscle or endothe-Elsevier Inc.lial cells in lesions as well as other impor-
tant features of the vulnerable plaque
(e.g., fibrous cap thickness). Neverthe-
less, this work provides an important
piece of the puzzle to the proposed role
of UPR in atherogenesis and highlights
yet another example of disease where
mitigating the CHOP function may be of
therapeutic benefit (Oyadomari et al.,
2002; Tamaki et al., 2008).
REFERENCES
Thorp,E., Li,G.,Seimon,T.A.,Kuriakose,G.,Ron,D.,
and Tabas, I. (2009). Cell Metab. 9, this issue, 474–
481.
Clarke,M.C.,Littlewood,T.D., Figg,N.,Maguire, J.J.,
Davenport, A.P., Goddard, M., and Bennett, M.R.
(2008). Circ. Res. 102, 1529–1538.
Feng, B., Yao, P.M., Li, Y., Devlin, C.M., Zhang, D.,
Harding, H.P., Sweeney, M., Rong, J.X.,
Kuriakose, G., Fisher, E.A., et al. (2003). Nat. Cell
Biol. 5, 781–792.
Cell Metabolism
PreviewsGargalovic, P.S., Gharavi, N.M., Clark, M.J.,
Pagnon, J., Yang, W.P., He, A., Truong, A.,
Baruch-Oren, T., Berliner, J.A., Kirchgessner,
T.G., and Lusis, A.J. (2006). Arterioscler. Thromb.
Vasc. Biol. 26, 2490–2496.
Mungrue, I.N., Pagnon, J., Kohannim, O.,
Gargalovic, P.S., and Lusis, A.J. (2009). J. Immu-
nol. 182, 466–476.Do Cancer Cells C
Michael Pollak1,*
1Departments of Medicine and Oncology and
*Correspondence: michael.pollak@mcgill.ca
DOI 10.1016/j.cmet.2009.04.006
A recent report by Kalaany and Sab
restriction on the growth of certain
relevance to oncology.
Recent progress in the field of ‘‘cancer
energetics’’ involves descriptions of the
influence of oncogenes and tumor
suppressor genes on the metabolic path-
ways used by cancer cells to generate
ATP (Jones and Thompson, 2009).
However, an important gap in knowledge
in this field involves an issue beyond the
cellular level—the influence of whole
organism energy balance on cancer
biology. The strong inhibitory effect of
host dietary restriction on the growth of
certain experimental tumors is a classic
observation that predates evenWarburg’s
work concerning cancer energetics, yet
studies concerning the mechanisms
underlying this phenomenon are sparse.
A recent paper (Kalaany and Sabatini,
2009) provides important data which add
to prior evidence that the inhibitory effect
of dietary restriction on tumor growth is
attributable to the effect of the diet on
insulin and insulin-like growth factors
(Figure 1). They confirm that restriction of
food intake lowers both insulin and IGF-I
levels and show that the degree of in vitro
mitogenic responsivity of various cell lines
to insulin or IGF-I can be used to predict
which corresponding xenografts will be
growth inhibited in vivo by dietary restric-
tion. Furthermore, they demonstrate that
PI3 kinase-activating mutation or loss ofMyoishi, M., Hao, H., Minamino, T., Watanabe, K.,
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atini concerning mechanisms under
tumors adds to the evidence that in
function of PTEN is sufficient to confer
resistance to the growth inhibitory effects
of dietary restriction.
A simple model to account for these
observations is that some cancers are
responsive to insulin and/or IGFs, and that
these neoplasms thrive when levels of
these mitogens are sufficient to contribute
to activation of the PI3K pathway. Many
studies are consistent with this hypothesis.
The implicated receptors are expressed by
many human cancers (e.g., Law et al.,
2008), and epidemiologic data (reviewed
in Pollak, 2008) provide evidence that high
circulating levels of the implicated ligands
are associated with adverse cancer prog-
nosis and/or increased cancer risk. Exam-
ples of consistent experimental data
include findings that tumor growth is
reduced in mice with mutations that lower
IGF-I levels (Majeed et al., 2005), and that
the growth inhibitory effect of caloric
restriction on a bladder cancer model can
be abolished by infusing IGF-I (Dunn
et al., 1997).
However, the simplest model may not
be complete. The dietary restriction
employed by Kalaany and Sabatini would
be expected to result in alterations in
additional hormones (such as leptin, adi-
ponectin, FGF21, and/or glucagon), and
an influence of these on neoplasms has
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lying the inhibitory effect of dietary
sulin and IGF-I are hormones with
not been excluded. Additional work to
compare in vitro the influences of physio-
logic concentrations of these hormones
to those of insulin and IGF-I would be of
interest. Measurements at later time
points of in vivo changes in AKT pathway
activation within cancers as a function of
host diet would also be relevant, as some
data reported concern tumors less than
20 mm3.
Apart from the effects of dietary restric-
tion on the hormonal environment of
cancers, does it reduce energy supply to
the tumor? Kalaany and Sabatini do not
report changes in glucose, amino acids,
or fatty acids associated with the degree
of caloric restriction employed. Such
measurements would be of interest, but it
is likely that the host breaks down muscle
and fat at sufficient rates tomaintain circu-
lating energy supply to normal tissues, and
to cancers. Therefore, host dietary restric-
tion may inhibit growth of certain cancers
through changes in hormone concentra-
tions rather than by causing energy deple-
tion at the cellular level.
What about the role of the energy sensor
AMP-activated kinase in tumor growth
inhibition by dietary restriction? In single-
cell organisms and in studies of cancer
cells in vitro, reduced supply of energy
sources leads toactivationofAMPK,which
lism 9, May 6, 2009 ª2009 Elsevier Inc. 401
